Sherif Suleiman
Impact in
-
- Wound Healing and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Circular RNAs in diseases 4
- Histone Deacetylase Inhibitors Research 2
- Cancer therapeutics and mechanisms 2
- RNA modifications and cancer 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 2
- Co-authors
- Jean Calleja‐Agius (16 shared papers)Pierre Schembri-Wismayer (6 shared papers)Riccardo Di Fiore (14 shared papers)Antonio Giordano (5 shared papers)Francesca Pentimalli (5 shared papers)Yashwanth Subbannayya (4 shared papers)Rosa Drago‐Ferrante (6 shared papers)Angel Yordanov (4 shared papers)
- Journals
- International Journal of Molecular Sciences (6 papers)European Journal of Surgical Oncology (3 papers)Tumor Biology (1 paper)Cancers (1 paper)Cancer Management and Research (1 paper)
- Partner nations
- MaltaUnited StatesItaly
In The Last Decade
Sherif Suleiman
19 papers receiving 216 citations
Peers
Comparison fields: 5 of 67
- Rehabilitation 28
- Cancer Research 38
- Oncology 37
- Aging 2
- Molecular Biology 77
Countries citing papers authored by Sherif Suleiman
This map shows the geographic impact of Sherif Suleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherif Suleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherif Suleiman more than expected).
Fields of papers citing papers by Sherif Suleiman
This network shows the impact of papers produced by Sherif Suleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherif Suleiman. The network helps show where Sherif Suleiman may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherif Suleiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 45 | |
| 2 | 2022 | 41 | |
| 3 | 2021 | 19 | |
| 4 | 2016 | 17 | |
| 5 | 2021 | 17 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2023 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2016 | 8 | |
| 11 | 2020 | 6 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 4 | |
| 14 | 2021 | 3 | |
| 15 | The axolotl model for cancer research: a mini-review. | 2020 | 3 |
| 16 | 2024 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2024 | 0 |
About Sherif Suleiman
Sherif Suleiman is a scholar working on Molecular Biology, Cancer Research, Oncology, Organic Chemistry and Obstetrics and Gynecology, having authored 20 papers that have together received 221 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), Cancer Cells and Metastasis (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer therapeutics and mechanisms (2 papers), MicroRNA in disease regulation (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Rehabilitation (28 citations), Cancer Research (38 citations), Oncology (37 citations), Aging (2 citations) and Molecular Biology (77 citations). Sherif Suleiman has collaborated with scholars based in Malta, United States and Italy. Frequent co-authors include Jean Calleja‐Agius, Pierre Schembri-Wismayer, Riccardo Di Fiore, Antonio Giordano, Francesca Pentimalli, Yashwanth Subbannayya, Rosa Drago‐Ferrante, Angel Yordanov, Mark P. Ward and Sharon O’Toole. Their work appears in journals such as International Journal of Molecular Sciences, European Journal of Surgical Oncology, Tumor Biology, Cancers and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.